Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Dec-23 4:19 PM View:  | AcelRx Pharmaceuticals, Inc. (TLPH) | 10-Oct-23 | Grant | 581 | -- | -- | 5% 10.59K to 11.17K | |
| 08-Jun-23 4:07 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-23 | Grant | 30,000 | -- | -- | 29% 104.8K to 134.8K | |
| 15-Jul-22 7:31 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Jul-22 | Grant | 15,500 | -- | -- | 8% 196.25K to 211.75K | |
| 09-Jun-22 4:56 PM View: | Akebia Therapeutics, Inc. (AKBA) | 08-Jun-22 | Grant | 13,700 | -- | -- | 15% 91.1K to 104.8K | |
| 19-Aug-21 5:23 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 18-Aug-21 | Market Purchase | 20,000 | $13.99 | $279,790.00 | 100% 0 to 20.0K | 14% |
| 17-Jun-21 5:32 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 17-Jun-21 | Grant | 10,000 | -- | -- | 5% 186.25K to 196.25K | |
| 03-Jun-21 5:27 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jun-21 | Grant | 13,700 | -- | -- | 18% 77.4K to 91.1K | |
| 16-Jun-20 7:13 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 16-Jun-20 | Grant | 7,500 | -- | -- | 4% 178.75K to 186.25K | |
| 15-Jun-20 6:01 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 15-Jun-20 | Market Purchase | 100,000 | $1.29 | $128,900.00 | (36%) 278.75K to 178.75K | 50% |
| 09-Jun-20 4:16 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jun-20 | Grant | 13,700 | -- | -- | 22% 63.7K to 77.4K | |
| 21-Nov-19 6:31 AM View: | Akebia Therapeutics, Inc. (AKBA) | 20-Nov-19 | Market Purchase | 50,000 | $3.41 | $170,500.00 | 365% 13.7K to 63.7K | (12%) |
| 25-Jun-19 7:00 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 25-Jun-19 | Grant | 3,750 | -- | -- | 5% 75.0K to 78.75K | |
| 10-Jun-19 4:03 PM View: | Akebia Therapeutics, Inc. (AKBA) | 06-Jun-19 | Grant | 13,700 | -- | -- | 100% 0 to 13.7K | |
| 12-May-17 9:53 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 11-May-17 | Grant | 218,380 | -- | -- | 6% 3.57M to 3.79M | |
| 17-Mar-17 4:16 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 15-Mar-17 | Market Purchase | 500,000 | $2.46 | $1,230,950.00 | 16% 3.07M to 3.57M | (99%) |
| 18-Mar-16 8:58 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 17-Mar-16 | Grant | 124,342 | -- | -- | 4% 2.94M to 3.07M | |
| 09-Feb-16 9:45 PM View: | Aralez Pharmaceuticals Inc. (ARLZ) | 05-Feb-16 | Acquisition (other) | 2,944,890 | -- | -- | 100% 0 to 2.94M | |
| 12-Nov-15 9:38 PM View: | Pozen, Inc. (POZN) | 12-Nov-15 | Market Purchase | 448,529 | $6.68 | $2,995,820.00 | 18% 2.5M to 2.94M | 7% |
| 12-Nov-15 9:38 PM View: | Pozen, Inc. (POZN) | 11-Nov-15 | Market Purchase | 551,471 | $6.45 | $3,556,710.00 | 28% 1.94M to 2.5M | 11% |
| 05-Jun-15 1:37 PM View: | Pozen, Inc. (POZN) | 03-Jun-15 | Grant | 1,944,890 | -- | -- | 100% 0 to 1.94M | |
| 30-Jan-15 9:33 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 29-Jan-15 | Disposition (other) | 217,778 | $20.15 | $4,388,500.00 | (100%) 217.78K to 0 | |
| 08-Dec-14 4:16 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 05-Dec-14 | Option Exercise | 40,000 | $17.40 | $696,000.00 | 18% 217.78K to 257.78K | |
| 08-Dec-14 4:16 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 05-Dec-14 | Market Option Sale | 40,000 | $33.97 | $1,358,700.00 | (16%) 257.78K to 217.78K | (1%) |
| 20-Feb-14 5:30 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 18-Feb-14 | Grant | 86,275 | -- | -- | 66% 131.5K to 217.78K | |
| 29-May-13 12:19 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 28-May-13 | Market Purchase | 50,000 | $8.39 | $419,500.00 | 200% 25.0K to 75.0K | (92%) |
| 29-May-13 12:19 PM View: | AcelRx Pharmaceuticals, Inc. (TLPH) | 24-May-13 | Market Purchase | 25,000 | $7.78 | $194,500.00 | 100% 0 to 25.0K | (91%) |
| 11-Feb-13 5:20 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 08-Feb-13 | Grant | 51,600 | -- | -- | 66% 78.56K to 130.16K | |
| 11-Feb-13 5:20 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 07-Feb-13 | Grant | 21,480 | -- | -- | 38% 57.08K to 78.56K | |
| 17-Dec-12 9:53 AM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 14-Dec-12 | Purchase | 56,000 | -- | -- | 9672% 0.58K to 56.58K | |
| 10-Aug-12 6:36 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 21,000 | $31.00 | $651,000.00 | (100%) 21.0K to 0 | |
| 17-May-12 5:44 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 15-May-12 | Grant | 3,000 | -- | -- | 17% 18.0K to 21.0K | |
| 17-Aug-11 4:32 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 15-Aug-11 | Grant | 15,000 | $10.74 | $161,095.00 | 500% 3.0K to 18.0K | |
| 25-May-11 5:03 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 24-May-11 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 16-May-11 6:24 PM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition | 446,875 | $5.00 | $2,234,380.00 | (69%) 650.0K to 203.13K | (< 1%) |
| 16-May-11 6:24 PM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 13-May-11 | Disposition (change in control) | 203,125 | $5.00 | $1,015,620.00 | (100%) 203.13K to 0 | (< 1%) |
| 19-Mar-10 11:22 AM View: | Inspire Pharmaceuticals, Inc. (ISPH) | 18-Mar-10 | Grant | 650,000 | -- | -- | 100% 0 to 650.0K | |
| 22-Oct-09 5:13 PM View: | Sepracor, Inc. (SEPR) | 20-Oct-09 | Disposition | 241,667 | $23.00 | $5,558,340.00 | (100%) 241.67K to 0 | < 1% |
| 19-Oct-09 5:19 PM View: | Sepracor, Inc. (SEPR) | 15-Oct-09 | Disposition (change in control) | 174,489 | $23.00 | $4,013,250.00 | (42%) 416.16K to 241.67K | < 1% |
| 14-May-09 9:43 PM View: | Sepracor, Inc. (SEPR) | 14-May-09 | Grant | 120,000 | $14.40 | $1,728,000.00 | 41% 296.16K to 416.16K | < 1% |
| 27-May-08 4:58 PM View: | Sepracor, Inc. (SEPR) | 27-May-08 | Market Purchase | 50,000 | $20.96 | $1,048,000.00 | 20% 245.0K to 295.0K | (30%) |
| 22-May-08 5:22 PM View: | Sepracor, Inc. (SEPR) | 20-May-08 | Grant | 120,000 | $21.26 | $2,551,200.00 | 96% 125.0K to 245.0K | (31%) |
| 12-Mar-07 8:47 PM View: | Sepracor, Inc. (SEPR) | 08-Mar-07 | Grant | 125,000 | $49.47 | $6,183,750.00 | 100% 0 to 125.0K | (71%) |
| 15-Dec-06 4:16 PM View: | Kos Pharmaceuticals Inc (KOSP) | 13-Dec-06 | Disposition (change in control) | 33,304 | $78.00 | $2,597,710.00 | (100%) 33.3K to 0 | |
| 30-Jan-06 8:36 PM View: | Kos Pharmaceuticals Inc (KOSP) | 26-Jan-06 | Grant | 29,400 | -- | -- | 785% 3.75K to 33.15K | |
| 17-Aug-05 12:17 PM View: | Kos Pharmaceuticals Inc (KOSP) | 16-Aug-05 | Market Sale (Planned) | 5,509 | $70.80 | $390,037.00 | 532% 1.04K to 6.54K | |
| 17-Aug-05 12:17 PM View: | Kos Pharmaceuticals Inc (KOSP) | 16-Aug-05 | Market Sale (Planned) | 2,800 | $71.19 | $199,321.00 | (43%) 6.54K to 3.75K | |
| 21-Jul-05 4:15 PM View: | Kos Pharmaceuticals Inc (KOSP) | 19-Jul-05 | Market Sale (Planned) | 8,309 | $74.99 | $623,053.00 | (41%) 20.35K to 12.04K | |
| 23-Jun-05 4:25 PM View: | Kos Pharmaceuticals Inc (KOSP) | 21-Jun-05 | Market Sale | 7,150 | $66.19 | $473,265.00 | (26%) 27.48K to 20.33K | |
| 19-May-05 3:14 PM View: | Kos Pharmaceuticals Inc (KOSP) | 17-May-05 | Market Sale | 7,150 | $53.64 | $383,529.00 | (21%) 34.62K to 27.47K | |
| 21-Apr-05 12:46 PM View: | Kos Pharmaceuticals Inc (KOSP) | 19-Apr-05 | Market Sale | 35,750 | $49.44 | $1,767,340.00 | (51%) 70.34K to 34.59K |